|
Racial disparities in patients with TP53 mutated acute myeloid leukemia. |
|
|
Stock and Other Ownership Interests - Aprea AB |
|
Consulting or Advisory Role - Pfizer |
|
|
Consulting or Advisory Role - Jazz Pharmaceuticals; Omeros |
Research Funding - Abbvie; Abbvie/Genentech; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Pluristem Therapeutics; Tolero Pharmaceuticals |
Other Relationship - Biosight |
|
|
Stock and Other Ownership Interests - Curis |
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Guilherme Sacchi de Camargo Correia |
No Relationships to Disclose |
|
|
Research Funding - Bristol-Myers Squibb/Celgene; Pfizer; SERVIER |
|
|
No Relationships to Disclose |
|
Guru Subramanian Guru Murthy |
Honoraria - Cardinal Health; Gilead Sciences; TG therapeutics |
Consulting or Advisory Role - Cancer Expert Now; Market Plus; Putnam Associates; Qessential Medical Marketing Research; SmartAnalyst; techspert.io |
Research Funding - Xencor |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Ambit BioSciences (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); H3 Biomedicine (Inst); MedImmune (Inst); Novartis (Inst); Onconova Therapeutics (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Moderna Therapeutics; Novavax |
Honoraria - Dava Oncology |
Consulting or Advisory Role - Abbvie; Aptose Biosciences; Astellas Pharma; Celgene; Daiichi Sankyo; Genentech |
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea Therapeutics (Inst); Arog (Inst); Celularity (Inst); Pfizer (Inst); Trillium Therapeutics (Inst) |
Travel, Accommodations, Expenses - Arog |
|
|
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis; Pfizer; Syndax; Takeda |
Speakers' Bureau - Abbvie; Celgene; Jazz Pharmaceuticals; Novartis |
Research Funding - Novartis (Inst); Takeda (Inst) |